tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
US Market

Arbutus Biopharma (ABUS) Cash flow

Compare
1,236 Followers

Arbutus Biopharma Cash Flow

ABUS's free cash flow for Q4 2024 was $-10.40M. For the 2024 fiscal year, ABUS's free cash flow was decreased by $22.09M and operating cash flow was $-10.31M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -64.85M$ -85.94M$ -35.36M$ -67.53M$ -51.44M
Investing Cash Flow
$ 22.95M$ 50.77M$ -74.94M$ -12.68M$ -14.91M
Financing Cash Flow
$ 52.00M$ 30.65M$ 31.81M$ 137.24M$ 86.75M
End Cash Position
$ 36.33M$ 26.29M$ 30.78M$ 109.28M$ 52.25M
Free Cash Flow
$ -64.85M$ -86.94M$ -35.87M$ -68.34M$ -51.67M
Currency in USD

Arbutus Biopharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis